v3.25.4
Capital Stock
12 Months Ended
Dec. 31, 2025
Stockholders' Equity Note [Abstract]  
Capital Stock

Note 10 — Capital Stock

Common Stock Outstanding

Common stock outstanding as of December 31, 2025, 2024 and 2023 was as follows:

(Number of shares in millions)

 

2025

 

 

2024

 

 

2023

 

Common stock:

 

 

 

 

 

 

 

 

 

Balance, beginning of year

 

111.6

 

 

110.8

 

 

110.4

 

Activity under stock plans

 

 

0.5

 

 

 

0.8

 

 

 

0.4

 

Balance, end of year

 

112.1

 

 

111.6

 

 

110.8

 

Treasury stock:

 

 

 

 

 

 

 

 

 

Balance, beginning of year

 

30.6

 

 

26.7

 

 

26.2

 

Repurchased

 

 

5.8

 

 

 

3.9

 

 

 

0.5

 

Balance, end of year

 

36.4

 

 

30.6

 

 

26.7

 

Common stock outstanding

 

 

75.7

 

 

 

81.0

 

 

 

84.1

 

 

On February 19, 2024, the Board approved a $300 million share repurchase plan (the “2024 Share Repurchase Plan”). As of December 31, 2025, the 2024 Share Repurchase Plan was fully utilized. The repurchases of the Company’s common stock under the 2024 Share Repurchase Plan were made in open market transactions, block transactions, privately negotiated purchase transactions or other purchase techniques at the discretion of management based upon consideration of market, business, legal, accounting, and other factors.

 

On October 22, 2025, the Board approved an additional $600 million share repurchase plan (the "2025 Share Repurchase Plan"), and, as part of the 2025 Share Repurchase Plan, the Company entered into accelerated share repurchase agreements (the "ASR") to purchase an aggregate of $350 million of the Company's common stock. On October 24, 2025, the Company paid Bank of America, N.A. (“Bank of America”) and Goldman Sachs & Co. LLC (together with Bank of America, the “Counterparties”) an aggregate amount of $350 million and received an initial delivery of approximately 3.95 million shares of the Company's common stock, representing 80% of the shares expected to be repurchased under the ASR agreement, at a price of $70.95 per share. The final number of shares to be repurchased will be based on the average of the daily volume-weighted average prices of the Company’s common stock during the term of the ASR Agreements, less a discount and subject to adjustments pursuant to the terms and conditions of the ASR Agreements. Upon final settlement of the ASR, under certain circumstances, each of the Counterparties may be required to deliver additional shares of common stock, or the Company may be required to deliver shares of common stock or to make a cash payment, at its election, to the Counterparties. The final settlement of each transaction under the ASR Agreements is scheduled to occur in the first quarter of 2026 and in each case may be accelerated at the option of the applicable Counterparty.

 

In connection with the ASR, on October 21, 2025, the Company provided notice to the lenders pursuant to the Credit Agreement to borrow $350.0 million under the Facility to fund the initial settlement of the ASR.

 

During the year ended December 31, 2025, we repurchased 5,720,616 shares of common stock, including the shares purchased pursuant to the ASR, under both repurchase plans at a cost of $454.3 million, including sales commissions and excise taxes, leaving approximately $380.6 million available for additional repurchases under the 2025 Share Repurchase Plan. The acquisition of these shares was accounted for under the treasury stock method.

 

Dividends per share of common stock for 2025 and 2024 were $0.68 and $0.60, respectively. For the years ended December 31, 2025 and 2024, we paid $53.9 million and $49.3 million in dividends for each year, respectively.